
浏览全部资源
扫码关注微信
重庆医科大学附属第一医院感染科
纸质出版日期:2011,
扫 描 看 全 文
[1]骆晓练,姚云清,谭燕,梅林,龚锐.siRNA治疗大鼠卡氏肺孢子菌肺炎的实验研究[J].重庆医科大学学报,2011,36(06):681-685.
LUO Xiao-lian, YAO Yun-qing, TAN Yan, et al. Study of the pneumocystis carinii pneumonia therapy effect of short interfering RNA targeting pneumocystis carinii major surface glycoprotein gene’s upstream conserved sequence[J]. Journal of Chongqing Medical University, 2011,36(6):681-685.
[1]骆晓练,姚云清,谭燕,梅林,龚锐.siRNA治疗大鼠卡氏肺孢子菌肺炎的实验研究[J].重庆医科大学学报,2011,36(06):681-685. DOI: 10.13406/j.cnki.cyxb.2011.06.013.
LUO Xiao-lian, YAO Yun-qing, TAN Yan, et al. Study of the pneumocystis carinii pneumonia therapy effect of short interfering RNA targeting pneumocystis carinii major surface glycoprotein gene’s upstream conserved sequence[J]. Journal of Chongqing Medical University, 2011,36(6):681-685. DOI: 10.13406/j.cnki.cyxb.2011.06.013.
目的:观察靶向卡氏肺孢子菌(Pneumocystis carinii
PC)主要表面糖蛋白(Major surface glycoprotein
MSG)DNA上游保守序列(Upstream conserved sequence
UCS)基因的siRNA对实验大鼠卡氏肺孢子菌肺炎(Pneumocystis carinii pneumonia
PCP)的治疗效果。方法:地塞米松皮下注射大鼠8周建立PCP动物模型
分为4组:A组
pPC-UCS组;B组
磺胺组;C组
感染对照组;D组
pTZU6+1对照组。大鼠存活率、体重、肺组织病理学变化、肺印片PC包囊数、扫描电镜下PC表面结构变化、ELISA检测大鼠血清IL-8、TNF-α水平作为疗效指标。结果:①各组大鼠均存活
存活率比较无意义。②A组与B组大鼠体重分别增长(13.16±3.97)g与(14.21±3.90)g
明显高于C组(4.32±2.06)g与D组(5.38±1.19)g
P<0.05。③与C组和D组比较
A组和B组大鼠肺组织炎症明显减轻。④A组与B组每视野包囊均数分别为(3.61±0.40)个与(3.17±0.28)个
明显低于C组(8.34±0.55)个与D组(8.74±0.57)个
P<0.05。⑤扫描电镜下
C组与D组PC表面结构完整
有密集的微绒毛结构;A组与B组PC表面微绒毛脱落
表膜出现深大缺损。⑥大鼠血清IL-8水平:A组与B组分别为(232.50±36.27)pg/ml与(201.15±34.52)pg/ml
明显低于C组(596.85±61.72)pg/ml与D组(555.10±54.31)pg/ml
P<0.05;大鼠血清TNF-α水平:A组与B组分别为(145.20±80.72)pg/ml与(172.65±76.27)pg/ml
明显高于C组(31.58±8.47)pg/ml与D组(39.49±12.03)pg/ml
P<0.05。结论:靶向PC MSG-UCS基因的siRNA对大鼠PCP有治疗作用。
Objective:To study the pneumocystis carinii pneumonia(PCP) therapy effect of short interfering RNA targeting pneumocystis carinii major surface glycoprotein(MSG) gene’s upstream conserved sequence(UCS).Methods:Rat PCP model was established by hypodermic injection of dexamethasone twice a week for 8 weeks.20 rats with PCP were randomly divided into 4 groups:in plasmid PC MSG-UCS treatment group(pPC-UCS group)
rats were injected with short interfering plasmid PC MSG-UCS 500 μg/kg day for eight days;in plasmid TZU6+1 treatment group(pTZU6+1 group)
rats were injected with empty plasmid TZU6+1 500 μg/kg day for eight days;in sulfadiazine treatment group
rats were treated with compound sulfadiazine 120 mg/kg day for eight days;and in PCP control group
rats were not given any treatment.For each group
the rat survival rate
rat body weight
pathological changes in rat lung tissues
the number of PC cysts in rat lung tissues
the surface structure changes of PC under scanning electron microscopy
interleukin 8 and tumour necrosis factor alpha(TNF-α)in the serum of rats were tested.Results:All of the rats in each groups survived at the end of treatment.Rat survival rate had no significant difference in group comparsion.All of the rats in each group got weight during the course of treatment.The mean increased body weight of rats in pPC-UCS group
sulfadiazine treatment group
pTZU6+1 group and PCP control group were(13.16±3.97) g
(14.21±3.90) g
(5.38±1.19) g and(4.32±2.06) g
respectively.Those in pPC-UCS group and sulfadiazine treatment group were significantly higher than those in pTZU6+1 group and PCP control group.The inflammation of rat lung tissues in pPC-UCS group and sulfadiazine treatment group were less than those in pTZU6+1 group and PCP control group.Under light microscopy the mean cyst number per field in the rat lung tissues in pPC-UCS group and sulfadiazine treatment group were 3.61±0.4 and 3.17±0.28
respectively
significantly smaller than those in pTZU6+1 group
8.74±0.55
and PCP control group
8.34±0.57.Under scanning electron microscopy
PC in pTZU6+1 group and PCP control group had intact surface with dense microvillus structure;on the contrary
in pPC-UCS group and sulfadiazine treatment group
the PC surface showed no microvillus but deep gap.Interleukin 8 in rat serum of pPC-UCS group and sulfadiazine treatment group were(232.50±36.27) pg/ml and(201.15±34.52) pg/ml
respectively
significantly lower than those of pTZU6+1 group
(596.85±61.72) pg/ml and PCP control group
(555.10±54.31) pg/ml.TNF-α in rat serum of pPC-UCS group and sulfadiazine treatment group were(145.20±80.72) pg/ml and(172.65±76.27) pg/ml
respectively
significantly higher than those of pTZU6+1 group
(39.49±12.03) pg/ml and PCP control group
(31.58±8.47) pg/ml.Conclusion:Short interfering RNA targeting pneumocystis carinii major surface glycoprotein gene’s upstream conserved sequence is effective in the treatment of rat pneumocystis carinii pneumonia.
siRNAMSG-UCS基因PCP治疗
siRNApneumocystis carinii MSG-UCSPCP therapy
0
浏览量
63
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621